Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...
HONG KONG, April 22, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is both pleased and honored to announce that its global first-in-class PD-1/VEGF bispecific antibody, ...
Throughout a person's lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette ...
Verification of a novel plasma eight-protein signature predicting long-term efficacy of first-line chemoimmunotherapy for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) plus pembrolizumab versus ...
The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results